Mitochondria 2010
 Mitochondria 2010 newsletter |
1st world congress on Targeting Mitochondria: Strategies, Innovations & Clinical Applications Workshop: Mitochondria & Skin-Ageing Programme Day 1 November 18th, 2010 9.00 Introduction: Antioxidants, Oxidative Stress and Mitochondria - 12th years ISANH Anniversary Pr M. Edeas, Chairman of ISANH, Paris, France 9.10 Targeting Mitochondria in 2010 and the future of medicine: a personal point of view Pr V. P. Skulachev, Moscow State University, Russia Session 1 Mitochondrial dysfunctions in chronic diseases and Pathologies: Recent advances & Perspectives 9.40 Overview on Mitochondria Dysfunctions in chronic diseases and pathologies: where we are now? Dr M. Duchen, University College of London, UK 10.10 Mitochondrial dysfunctions and cellular energetic depression: Implications in Pathologies Dr E. Seppet, University of Tartu, Estonia 10.45 Break Business to Business Session 11.15 Are oxidative phosphorylation defects an accompanying phenomenon or an essential step in chronic diseases pathogeny ? Dr A. Lombès, University Pierre et Marie Curie, France 11.45 Mitochondria or Bacteria? Circulating mitochondrial cause inflammatory responses to injury Dr C. J. Hauser, Harvard Medical School, USA 12.15 Short oral presentations upon abstract submission Expression of UCP1 in skeletal muscle in mice: effects on aging and longevity Mrs S. Keipert, German Institute of Human Nutrition, Germany 12.30 Lunch break Session 2 Mitochondria into practice: Methods & Instruments to evaluate Drugs, Cosmetic, Nutraceutical & Nutrients’ efficacy on Mitochondria 14.00 Live cell quantification of mitochondrial parameters in living (patient) cells Dr W. J. H. Koopman, Radboud University Nijmegen Medical Center, Netherlands 14.30 Methods and devices for assessment of mitochondrial parameters in vivo: Innovations and Perspectives Dr E. G. Mik, Department of Anesthesiology, Erasmus Medical Center, Netherlands 15.00 Roundtable Hot Topic discussion: How can we standardize all methods to detect Mitochondrial dysfunctions Special focus on OXPHOX, ROS, DYm, MPTP…. 15.30 Break Business to Business Session Session 3 Development and Creation of mitochondria controlled by chemically synthesized genome to treat and prevent diseases: Myth or Reality? 16.00 Prospects for creation of mitochondria controlled by chemically synthesized genome Pr J. Glass, John Craig Venter Institute, USA 16.30 Discussion 16.45 Short oral presentations upon abstract submission on innovative methods, mitochondrial dysfunctions in neurodegenerative diseases, diabetes, cardiovascular diseases, aging, cancer, hypoxia/ischemia… 17.30 End of the first day 20.00 Speakers’ dinner Day 2 November 19th, 2010 Session 4 Strategies and Innovations to Target Mitochondria: Recent Clinical data and potential Therapeutic Studies 9.00 Extending Lifespan and Promoting Metabolic Health by Transiently Increasing Oxidative Stress - The Concept of Mitohormesis Dr M. Ristow, University of Jena, Germany 9.30 Mitochondria-targeted Pharmaceutical Nanocarriers Pr V. Weissig, Midwestern University College of Pharmacy Glendale, USA 10.00 Mitochondria as a target for cancer-chemotherapy: Recent Advances and therapeutic strategies Dr V. Gogvadze, Karolinska Institute of Stockolm, Sweden 10.30 Break Business to Business Session 11.00 Targeting of new classes of anti-apoptotic drugs into mitochondria: challenges and perspectives Dr V. E. Kagan, University of Pittsburg, USA 11.30 Can we modulate Mitochondrial morphology and dynamics as a therapeutic approach ? Dr M. Rojo, University of Bordeaux, France 12.00 Mitochondria and Diabetes: Mitochondria as a target for insulin resistance: antioxidants applications as a potential therapy Dr V. M. Victor Gonzalez, University of Valencia, Spain 12.30 Discussion about Sirtuins and Mitochondrial's story: Sciences, Speculation, Marketing so what is next…? 12.45 Lunch Break WORKSHOP Mitochondria and Skin-Ageing Mitochondria as a target for ageing and skin disorders: Antioxidants applications as potential therapy and anti-ageing effects 14.00 Role of Mitochondria in photoageing of human skin: the defective powerhouse model Dr P. Schroeder, University of Dusseldorf, Germany 14.30 Optimizing Mitochondrial Function as a target for anti-aging skin care Dr G.-M. Muhr, Manager Ageing Skin, R&D Beiersdorf AG, Hamburg, Germany 15.00 Short oral presentation upon abstract submission: Innovations on Skin-Ageing and Skin-Ageing Products 15.30 Break Business to Business Session 16.00 How to boost mitochondria activities and metabolism by natural or synthetic ingredients? Call for short oral presentations upon abstract submission 16.30 General discussion and conclusion of Targeting Mitochondria 2010 Targeting Mitochondria 2010Awards 17.00 End of the Conference Business to Business: An exhibition space dedicated to Mitochondrial Devices, Innovations, Arrays and Products (…) will be held during the two days. This Network session shall promote knowledge synergies, introduce to new techniques and methods, to directly share information with industrials, clinicians and researchers. If you need more information, don’t’ hesitate to contact us isanh-conferences@orange.fr |
NewsSponsor |
